Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Universal nirsevimab slashes RSV infant hospitalizations, study suggests​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Pfizer’s RSV vaccine safe to use during pregnancy, study suggests​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Studies: RSV prevention strategies—especially nirsevimab—may cut infant hospitalizations​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV confers similar risk of poor outcomes in hospitalized patients as flu over time, data suggest​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV vaccine protects older adults, and drug protects babies, but less so over time, studies suggest​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Recently approved RSV prevention therapies may be next FDA target​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV tied to heart problems, breathing issues well after infection in adults​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV vaccine highly effective against hospital admission in older adults, study suggests​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Nirsevimab prevents RSV cases in young kids for 1 year but maybe not beyond, data suggest​
Load More
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Medical societies recommend RSV vaccines for older or immune-compromised adults​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Up to 56,000 people died from COVID-19 or RSV last year​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Rapid RSV tests linked to less antibiotic prescribing in kids​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Up to 56,000 people died from COVID-19 or RSV last year​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu activity still high, with 8 more pediatric deaths​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
CDC reports 6 more child deaths from flu, as virus levels stay moderate to high​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Study ties adult RSV hospitalization to a higher risk of heart and lung problems in next 6 months​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Analysis suggests nirsevimab cuts infant RSV hospitalizations 83%​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Most Americans would recommend RSV immunizations for older adults, infants, pregnant women​